[Thirty years' experience in following up patients with nonspecific respiratory diseases].
The paper sums up the work of the Diagnosis Department of the Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences in the past 30 years. It also presents the results of examinations, treatment, and follow-ups of 5000 patients with sarcoidosis, exogenous allergic alveolitis, pulmonary tuberculosis of questionable activity, pneumonia, benign and malignant tumors, respiratory malformations, systemic vasculitis, pulmonary eosinophilia, lymphogranulomatosis, and rare lung diseases.
Ozerova
L V
LV
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D011014:Pneumonia / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D011239:Prednisolone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D012141:Respiratory Tract Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D017565:Sarcoidosis, Pulmonary / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy
D000893:Anti-Inflammatory Agents; D003524:Cyclosporins; D011239:Prednisolone